MedPath

KRN-5500

Generic Name
KRN-5500
Drug Type
Small Molecule
Chemical Formula
C28H43N7O7
CAS Number
151276-95-8
Unique Ingredient Identifier
8VH13L5K20

Overview

KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).

Background

KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Completed
Posted: 2007/05/17
Sponsor:
DARA Therapeutics

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath